Phospholamban: Protein structure, mechanism of action, and role in cardiac function

Physiological Reviews

Volumn 78, Issue 4, 1998, Pages 921-947

  Simmerman, Heather K B ^a   Jones, Larry R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; PHOSPHOLAMBAN;

ANIMAL CELL; ANIMAL TISSUE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; HEART DILATATION; HEART FAILURE; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT; REVIEW;

EID: 0031722958     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.1998.78.4.921     Document Type: Review

References (269)

1. AHMAD, Z., F. J. GREEN, H. SUBUHI, AND A. M. WATANABE. Autonomic regulation of type 1 protein phosphatase in cardiac muscle. J. Biol. Chem. 264: 3859-3863, 1989.
2. 2-adrenergic stimulation. Circulation 92: 1612-1618, 1995.
3. AMBUDKAR, I. S., AND A. E. SHAMOO. Role of phospholamban in regulating cardiac sarcoplasmic reticulum calcium pump. Membr. Biochem. 5: 119-130, 1984.
4. 2+ pump mechanism. Biochim. Biophys. Acta 988: 47-72, 1989.
5. ANTIPENKO, A. Y., A. I. SPIELMAN, AND M. A. KIRCHBERGER. Comparison of the effects of phospholamban and jasmone on the calcium pump of cardiac sarcoplasmic reticulum. J. Biol. Chem. 272: 2852-2860, 1997.
6. ANTIPENKO, A. Y., A. I. SPIELMAN, M. SASSAROLI, AND M. A. KIRCHBERGER. Comparison of the kinetic effects of phospholamban phosphorylation and anti-phospholamban monoclonal antibody on the calcium pump in purified cardiac sarcoplasmic reticulum membranes. Biochemistry 36: 12903-12910, 1997.
7. ARAI, M., N. R. ALPERT, D. H. MACLENNAN, P. BARTON, AND M. PERIASAMY. Alterations in sarcoplasmic gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ. Res. 72: 463-469, 1993.
8. ARKIN, I. T., P. D. ADAMS, A. T. BRÜNGER, S. O. SMITH, AND D. M. ENGELMAN. Structural perspectives of phospholamban, a helical transmembrane pentamer. Annu. Rev. Biophys. Biomol. Struct. 26: 157-179, 1997.
9. ARKIN, I. T., P. D. ADAMS, K. R. MACKENZIE, M. A. LEMMON, A. T. BRÜNGER, AND D. M. ENGELMAN. Structural organization of the pentameric transmembrane alpha-helices of phospholamban, a cardiac ion channel. EMBO J. 13: 4757-4764, 1994.
10. ARKIN, I. T., K. R. MACKENZIE, L. FISHER, S. AIMOTO, D. M. ENGELMAN, AND S. O. SMITH. Mapping the lipid-exposed surfaces of membrane proteins. Nature Struct. Biol. 3: 240-243, 1996.
11. ARKIN, I. T., M. ROTHMAN, C. F. C. LUDLAM, S. AIMOTO, D. M. ENGELMAN, K. J. ROTHSCHILD, AND S. O. SMITH. Structural model of the phospholamban ion channel complex in phospholipid membranes. J. Mol. Biol. 248: 824-834, 1995.
12. AUTRY, J. M., S. E. CALA, B. T. SCOTT, AND L. R. JONES. High level co-expression of the canine cardiac calcium pump and phospholamban in Sf21 insect cells. Ann. NY Acad. Sci. 853: 92-102, 1998.
13. 2+-pump and phospholamban in Sf21 cells reveals new insights on ATPase regulation. J. Biol. Chem. 272: 15872-15880, 1997.
14. BEEKMAN, R. E., C. VANHARDEVELD, AND W. S. SIMONIDES. On the mechanism of the reduction by thyroid hormone of β-adrenergic relaxation rate stimulation in rat heart. Biochem. J. 259: 229-236, 1989.
15. BIDLACK, J. M., I. S. AMBUDKAR, AND A. E. SHAMOO. Purification of phospholamban, a 22,000-dalton protein from cardiac sarcoplasmic reticulum that is specifically phosphorylated by cyclic AMP-dependent protein kinase. J. Biol. Chem. 257: 4501-4506, 1982.
16. BIDLACK, J. M., AND A. E. SHAMOO. Adenosine 3′,5′-monophosphate-dependent phosphorylation of a 6,000 and a 22,000-dalton protein from cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta 632: 310-325, 1980.
17. BILEZIKJIAN, L. M., E. G. KRANIAS, J. D. POTTER, AND A. SCHWARTZ. Studies on phosphorylation of canine cardiac sarcoplasmic reticulum by calmodulin-dependent protein kinase. Circ. Res. 49: 1356-1362, 1981.
18. BOHM, M., B. REIGER, R. H. G. SCHWINGER, AND E. ERDMANN. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc. Res. 28: 1713-1719, 1994.
19. BOYOT, P., B. LUU, L. R. JONES, AND E. TRIFILIEFF. Purification of phospholamban from bovine cardiac muscle with organic solvents. Arch. Biochem. Biophys. 269: 639-645, 1989.
20. BRIGGS, N. F., K. F. LEE, J. J. FEHER, A. S. WECHSLER, K. OHLENDIECK, AND K. P. CAMPBELL. Ca-ATPase isozyme expression in sarcoplasmic reticulum is altered by chronic stimulation of skeletal muscle. FEBS Lett. 259: 269-272, 1990.
21. 2+-ATPase. J. Biol. Chem. 267: 26056-26061, 1992.
22. 2+ pump. J. Biol. Chem. 264: 18561-18568, 1989.
23. 2+. J. Biol. Chem. 268: 17018-17025, 1993.
24. CAPONY, J.-P., M. L. RINALDI, F. GUILLEUX, AND J. G. DEMAILLE. Isolation of cardiac membrane proteolipids by high pressure liquid chromatography: a comparison of reticular and sarcolemmal proteolipids, phospholamban and calciductin. Biochim. Biophys. Acta 728: 83-91, 1983.
25. CHEN, W., M. LAH, P. J. ROBINSON, AND B. E. KEMP. Phosphorylation of phospholamban in aortic smooth muscle cells and heart by calcium/calmodulin-dependent protein kinase II. Cell. Signal. 6: 617-630, 1994.
26. CHIESI, M., J. GASSER, AND E. CARAFOLI. Phospholamban of cardiac sarcoplasmic reticulum consists of two functionally distinct proteolipids. FEBS Lett. 160: 61-66, 1983.
27. CHIESI, M., AND R. SCHWALLER. Involvement of electrostatic phenomena in phospholamban-induced stimulation of Ca uptake into cardiac sarcoplasmic reticulum. FEBS Lett. 244: 241-244, 1989.
28. 2+-ATPase by tannin. Biochem. Biophys. Res. Commun. 202: 1668-1673, 1994.
29. 2+-pumping ATPase. Biochemistry 30: 7978-7983, 1991.
30. CHU, G., G. W. DORN II, W. LUO, J. M. HARRER, V. J. KADAMBI, R. A. WALSH, AND E. G. KRANIAS. Monomeric phospholamban overexpression in transgenic mouse hearts. Circ. Res. 81: 485-492, 1997.
31. CHU, G., W. LUO, J. P. SLACK, C. TILGMANN, W. E. SWEET, M. SPINDLER, K. W. SAUPE, G. P. BOIVIN, C. S. MORAVEC, M. A. MATLIB, I. L. GRUPP, J. S. INGWALL, AND E. G. KRANIAS. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ. Res. 78: 1064-1076, 1996.
32. COLLINS, J. G., E. G. KRANIAS, A. S. REEVES, L. M. BILEZIKJIAN, AND A. SCHWARTZ. Isolation of phospholamban and a second proteolipid component from canine cardiac sarcoplasmic reticulum. Biochem. Biophys. Res. Commun. 99: 796-803, 1981.
33. COLYER, J. Control of the calcium pump of cardiac sarcoplasmic reticulum. A specific role for the pentameric structure of phospholamban? Cardiovasc. Res. 27: 1766-1771, 1993.
34. COLYER, J., AND J. H. WANG. Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban. J. Biol. Chem. 266: 17486-17493, 1991.
35. COOK, E. A., J. P. HUGGINS, G. SATHE, P. J. ENGLAND, AND J. R. PIGGOTT. The expression of canine cardiac phospholamban in heterologous systems. Biochem. J. 264: 533-538, 1989.
36. CORNEA, R. L., L. R. JONES, J. M. AUTRY, AND D. D. THOMAS. Mutation and phosphorylation change the oligomeric state of phospholamban in lipid bilayers. Biochemistry 36: 2960-2967, 1997.
37. CORNWELL, T. L., K. B. PRYZWANSKI, T. A. WYATT, AND T. M. LINCOLN. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol. Pharmacol. 40: 923-931, 1991.
38. DAVIS, B. A., I. EDES, R. C. GUPTA, E. F. YOUNG, H. W. KIM. N. A. E. STEENAART, G. SZYMANSKA, AND E. G. KRANIAS. The role of phospholamban in the regulation of calcium transport by cardiac sarcoplasmic reticulum. Mol. Cell. Biochem. 99: 83-88, 1990.
39. - channel. J. Membr. Biol. 146: 315-326, 1995.
40. DIECKMANN, G. R., AND W. F. DEGRADO. Modeling transmembrane and helical oligomers. Curr. Opin. Struct. Biol. 7: 486-494, 1997.
41. DRAGO, G. A., AND J. COLYER. Discrimination between two sites of phosphorylation on adjacent amino acids by phosphorylation site-specific antibodies. J. Biol. Chem. 269: 25073-25077, 1994.
42. EDES, I., AND E. G. KRANIAS. Regulation of cardiac sarcoplasmic reticulum function by phospholamban. Membr. Biochem. 7: 175-192, 1987.
43. EDES, I., AND E. G. KRANIAS. Phospholamban and troponin I are substrates for protein kinase C in vitro hut not in intact beating guinea pig hearts. Circ. Res. 67: 394-400, 1990.
44. 2+-transport ATPases of vascular smooth muscle. Circ. Res. 62: 266-278, 1988.
45. 2+-pump isoforms and of phospholamban in pig smooth-muscle tissues. Biochem. J. 271: 649-653, 1990.
46. FELDMAN, A., E. R. PHILLIP, C. M. SILAN, J. A. MERCER, W. MINOBE, AND M. R. BRISTOW. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation 83: 1866-1872, 1991.
47. FERGUSON, D. G., E. F. YOUNG, L. RAEYMAEKERS, AND E. G. KRANIAS. Localization of phospholamban in smooth muscle using immunogold electron microscopy. J. Cell Biol. 107: 555-562, 1988.
48. FLEISCHER, S. Phospholamban, phosphorylation, and phosphorescence. Biophys. J. 67: 3-4, 1994.
49. 2+-ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J. Mol. Med. 74: 321-332, 1996.
50. FLOCKERZI, V., R. MEWES, P. RUTH, AND F. HOFMAN. Phosphorylation of purified bovine cardiac sarcolemma and potassium-stimulated calcium uptake. Eur. J. Biochem. 135: 131-142, 1983.
51. FOWLER, C., J. P. HUGGINS, C. HALL, C. J. RESTALL, AND D. CHAPMAN. The effects of calcium, temperature and phospholamban phosphorylation on the dynamics of the calcium-stimulated ATPase of canine cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta 980: 348-356, 1989.
52. FUJII, J., M. KADOMA, M. TADA, H. TADA, AND F. SAKIYAMA. Characterization of structural unit of phospholamban by amino acid sequencing and electrophoretic analysis. Biochem. Biophys. Res. Commun. 138: 1044-1050, 1986.
53. FUJII, J., J. LYTTON, M. TADA, AND D. H. MACLENNAN. Rabbit cardiac and slow-twitch muscle express the same phospholamban gene. FEBS Lett. 227: 51-55, 1988.
54. FUJII, J., K. MARUYAMA, M. TADA, AND D. H. MACLENNAN. Expression and site-specific mutagenesis of phospholamban: studies of residues involved in phosphorylation and pentamer formation. J. Biol. Chem. 264: 12950-12955, 1989.
55. 2+-ATPase (SERCA2) and phospholamban. FEBS Lett. 273: 232-234, 1990.
56. FUJII, J., A. UENO, K. KITANO, S. TANAKA, M. KADOMA, AND M. TADA. Complete complemetary DNA-derived amino acid sequence of canine cardiac phospholamban. J. Clin. Invest. 79: 301-304, 1987.
57. FUJII, J., A. ZARAIN-HERZBERG, H. F. WILLARD, M. TADA, AND D. H. MACLENNAN. Structure of the rabbit phospholamban gene, cloning of the human cDNA, and assignment of the gene to human chromosome 6. J. Biol. Chem. 266: 11669-11675, 1991.
58. GANIM, J. R., W. LUO, S. PONNIAH, I. GRUPP, H. W. KIM, D. G. FERGUSON, V. KADAMBI, J. C. NEUMANN, T. DOETSCHMAN, AND E. G. KRANIAS. Mouse phospholamban gene expression during development in vivo and in vitro. Circ. Res. 71: 1021-1030, 1992.
59. GARVEY, J. L., E. G. KRANIAS, AND R. J. SOLARO. Phosphorylation of C protein, troponin I, and phospholamban in isolated rabbit hearts. Biochem. J. 249: 709-714, 1988.
60. GASSER, J. T., M. P. CHIESI, AND E. CARAFOLI. Concerted phosphorylation of the 26-kilodalton phospholamban oligomer and of the low molecular weight phospholamban subunits. Biochemistry 25: 7615-7623, 1986.
61. GREENGARD, P. Phosphorylated proteins as physiological effectors. Science 199: 146-152, 1978.
62. GRUPP, I. L., E. G. KRANIAS, J. M. HARRER, E. KISS, J. SLACK, K. L. KOSS, I. EDES, W. LUO, AND G. GRUPP. The contribution of phospholamban, a sarcoplasmic reticulum phosphoprotein, to myocardial contractility in health and disease. Heart Failure 11: 48-61, 1995.
63. GUPTA, R. C., AND E. G. KRANIAS. Purification and characterization of a calcium-calmodulin-dependent phospholamban kinase from canine myocardium. Biochemistry 28: 5909-5916, 1989.
64. HAGHIGHI, K., V. J. KADAMBI, K. L. KOSS, W. LUO, J. M. HARRER, S. PONNIAH, Z. ZHOU, AND E. G. KRANIAS. In vitro and in vivo promoter analyses of the mouse phospholamban gene. Gene 203: 199-207, 1997.
65. 2+-ATPase. Circ. Res. 81: 145-153, 1997.
66. HARRER, J. M., AND E. G. KRANIAS. Characterization of the molecular form of cardiac phospholamban. Mol. Cell. Biochem. 140: 185-193, 1994.
67. 12 cells and regulation of endogenous SERCA1 activity. Mol. Cell. Bioehem. 146: 13-21, 1995.
68. HARTMANN, M., AND J. SCHRADER. Protein kinase C phosphorylates a 15 kDa protein but not phospholamban in intact rat cardiac myocytes. Eur. J. Pharmacol. 226: 225-231, 1992.
69. 2+-ATPase in failing and nonfailing human myocardium. Circ. Res. 75: 434-442, 1994.
70. HERZYK, P., AND R. E. HUBBARD. Using experimental information to produce a model of the transmembrane domain of the ion channel phospholamban. Biophys. J. 74: 1203-1214, 1998.
71. HICKS, M., M. SHIGEKAWA, AND A. M. KATZ. Mechanism by which cyclic adenosine 3′:5′-monophosphate-dependent protein kinase stimulates calcium transport in cardiac sarcoplasmic reticulum. Circ. Res. 44: 384-391, 1979.
72. HOIT, B. D., S. F. KHOURY, E. G. KRANIAS, N. BALL, AND R. A. WALSH. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ. Res. 77: 632-637, 1995.
73. HOLTZHAUER, M., H. SYDOW, AND T. S. LEVCHENKO. The putative role of phospholamban in the regulation of the heart muscle. Biomed. Biochim. Acta 45: S233-S236, 1986.
74. HU, P., C. YIN, K.-M. ZHANG, L. D. WRIGHT, T. E. NIXON, A. S. WECHSLER, J. A. SPRATT, AND F. N. BRIGGS. Transcriptional regulation of phospholamban gene and translational regulation of SERCA2 gene produce coordinate expression of these two sarcoplasmic reticulum proteins during skeletal muscle phenotype switching. J. Biol. Chem. 270: 11619-11622, 1995.
75. HU, P., K.-M. ZHANG, J. A. SPRATT, A. S. WECHSLER, AND F. N. BRIGGS. Transcription rates of SERCA and phospholamban genes change in response to chronic stimulation of skeletal muscle. Biochim. Biophys. Acta 1395: 121-125, 1998.
76. HUBBARD, M. J., P. DENT, C. SMYTHE, AND P. COHEN. Targeting of protein phosphatase 1 to the sarcoplasmic reticulum of rabbit skeletal muscle by a protein that is very similar or identical to the G subunit that directs the enzyme to glycogen. Eur. J. Biochem. 189: 243-249, 1990.
77. HUBBARD, J. A., L. K. MACLACHLAN, E. MEENAN, C. J. SALTER, D. G. REID, P. LAHOURATATE, J. HUMPHRIES, N. STEVENS, D. BELL, W. A. NEVILLE, K. J. MURRAY, AND J. G. DARKER. Conformation of the cytoplasmic domain of phospholamban by NMR and CD. Mol. Membr. Biol. 11: 263-269, 1994.
78. HUGGINS, J. P., E. A. COOK, J. R. PIGGOTT, T. J. MATTINSLEY, AND P. J. ENGLAND. Phospholamban is a good substrate for cyclic GMP-dependent protein kinase in vitro, but not in intact cardiac or smooth muscle. Biochem. J. 260: 829-835, 1989.
79. HUGGINS, J. P., AND P. J. ENGLAND. Sarcolemmal phospholamban is phosphorylated in isolated rat hearts perfused with isoprenaline. FEBS Lett. 163: 297-302, 1983.
80. HUGGINS, J. P., AND P. J. ENGLAND. Evidence for a phosphorylation-induced conformational change in phospholamban from the effects of three proteases. FEBS Lett. 217: 32-36, 1987.
81. 2+-ATPase. Biochem. J. 303: 511-516, 1994.
82. 2+-ATPase by phospholamban. Biochem. J. 318: 973-979, 1996.
83. HWANG, K. S., AND B. NADAL-GINARD. Cloning phospholamban cDNA from rat aortic smooth muscle. Adv. Exp. Med. Biol. 304: 387-395, 1991.
84. IMAGAWA, T., T. WATANABE, AND T. NAKAMURA. Subunit structure and multiple phosphorylation sites of phospholamban. J. Biochem. 99: 41-53, 1986.
85. 2+ transport as studied by reconstitution of cardiac sarcoplasmic reticulum. J. Biol. Chem. 261: 1794-1800, 1986.
86. INUI, M., M. KADOMA, AND M. TADA. Purification and characterization of phospholamban from canine cardiac sarcoplasmic reticulum. J. Biol. Chem. 260: 3708-3715, 1985.
87. IWASA, Y., AND M. M. HOSEY. Phosphorylation of cardiac sarcolemma proteins by the calcium-activated phospholipid-dependent protein kinase. J. Biol. Chem. 259: 534-540, 1984.
88. 2+ ATPase inhibition by phospholamban phosphorylation (Abstract). Biochem. Soc. Trans. 62S: 23, 1995.
89. 2+-pump stimulation. Biochem. J. 316: 201-207, 1996.
90. JAKAB, G., AND E. G. KRANIAS. Phosphorylation and dephosphorylation of purified phospholamban and associated phosphatidylinositides. Biochemistry 27: 3799-3806, 1988.
91. 2+ pump of sarcoplasmic reticulum. Nature 342: 90-92, 1989.
92. JOHNS, D. C., AND A. M. FELDMAN. Identification of a highly conserved region at the 5′ flank of the phospholamban gene. Biochem. Biophys. Res. Commun. 188: 927-933, 1992.
93. JONES, L. R. Sarcolemmal enzymes mediating β-adrenergic effects on the heart. Curr. Top. Membr. Transp. 25: 11-41, 1985.
94. JONES, L. R., H. R. BESCH, J. W. FLEMING, M. M. McCONNAUGHEY, AND A. M. WATANABE. Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum: comparative biochemical analysis of component activities. J. Biol. Chem. 254: 530-539, 1979.
95. 2+ transport ATPase of cardiac sarcoplasmic reticulum. J. Biol. Chem. 268: 11486-11488, 1993.
96. JONES, L. R., S. W. MADDOCK, AND D. R. HATHAWAY. Membrane localization of myocardial type II cAMP-dependent protein kinase activity. Biochim. Biophys. Acta 641: 242-253, 1981.
97. JONES, L. R., H. K. B. SIMMERMAN, W. W. WILSON, F. R. N. GURD, AND A. D. WEGENER. Purification and characterization of phospholamban from canine cardiac sarcoplasmic reticulum. J. Biol. Chem. 260: 7721-7730, 1985.
98. JONES, L. R., A. D. WEGENER, AND H. K. B. SIMMERMAN. Purification of phospholamban from canine cardiac sarcoplasmic reticulum vesicles by use of sulfhydryl group affinity chromatography. Methods Enzymol. 157: 360-369, 1988.
99. JORGENSEN, A. O., AND L. R. JONES. Localization of phospholamban in slow but not fast canine skeletal muscle fibers: an immunocytochemical and biochemical study. J. Biol. Chem. 261: 3775-3781, 1986.
100. JORGENSEN, A. O., AND L. R. JONES. Immunoelectron microscopical localization of phospholamban in adult canine ventricular muscle. J. Cell Biol. 104: 1343-1352, 1987.
101. 2+-release channel/ryanodine receptor is localized in junctional and corbular sarcoplasmic reticulum in cardiac muscle. J. Cell Biol. 120: 969-980, 1993.
102. KADAMBI, V. J., AND E. G. KRANIAS. Phospholamban: a protein coming of age. Biochem. Biophys. Res. Commun. 239: 1-5, 1997.
103. KADAMBI, V. J., S. PONNIAH, J. M. HARRER, B. D. HOIT, G. W. DORN II, R. A. WALSH, AND E. G. KRANIAS. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J. Clin. Invest. 97: 533-539, 1996.
104. KARCZEWSKI, P., S. BARTEL, H. HAASE, AND E.-G. KRAUSE. Isoproterenol induces both cAMP- and calcium-dependent phosphorylation of phospholamban in canine heart in vivo. Biomed. Biochim. Acta 46: S433-S439, 1987.
105. KARCZEWSKI, P., S. BARTEL, AND E.-G. KRAUSE. Differential sensitivity to isoprenaline of troponin I and phospholamban phosphorylation in isolated rat hearts. Biochem. J. 266: 115-122, 1990.
106. KARCZEWSKI, P., M. KELM, M. HARTMANN, AND J. SCHRADER. Role of phospholamban in NO/EDRF-induced relaxation in rat aorta. Life Sci. 51: 1205-1210, 1992.
107. KATZ, A. M., R. A. COLVIN, AND T. ASHAVAID. Phospholamban and calciductin. J. Mol. Cell. Cardiol. 15: 795-797, 1983.
108. 2+-ATPase with phospholamban in phospholipid vesicles. J. Biol. Chem. 265: 1702-1709, 1990.
109. KIMURA, Y., M. INUI, M. KADOMA, Y. KIJIMA, T. SASAKI, AND M. TADA. Effects of monoclonal antibody against phospholamban on calcium pump ATPase of cardiac sarcoplasmic reticulum. J. Mol. Cell. Cardiol. 23: 1223-1230, 1991.
110. 2+-ATPase through intramembrane interactions. J. Biol. Chem. 271: 21726-21731, 1996.
111. KIMURA, Y., K. KURZYDLOWSKI, M. TADA, AND D. H. MACLENNAN. Phospholamban inhibitory function is activated by depolymerization. J. Biol. Chem. 272: 15061-15064, 1997.
112. 2+ ATPase and decreasing phospholamban expression. J. Mol. Cell. Cardiol. 26: 1145-1154, 1994.
113. KIRCHBERGER, M. A., AND T. ANTONETZ. Phospholamban: dissociation of the 22,000 molecular weight protein of cardiac sarcoplasmic reticulum into 11,000 and 5,500 molecular weight forms. Biochem. Biophys. Res. Commun. 105: 152-156, 1982.
114. 2+)-activated ATPase activity in isolated cardiac sarcoplasmic reticulum. J. Biol. Chem. 257: 5685-5691, 1982.
115. KIRCHBERGER, M. A., D. BORCHMAN, AND C. KASINATHAN. Proteolytic activation of the canine cardiac sarcoplasmic reticulum calcium pump. Biochemistry 25: 5484-5492, 1986.
116. KIRCHBERGER, M. A., AND A. RAFFO. Decrease in calcium transport associated with phosphoprotein phosphatase-catalyzed dephosphorylation of cardiac sarcoplasmic reticulum. J. Cyclic Nucleotide Res. 3: 45-53, 1997.
117. KIRCHBERGER, M. A., AND M. TADA. Effects of adenosine 3′,5′-monophosphate dependent protein kinase on sarcoplasmic reticulum isolated from cardiac and slow and fast contracting skeletal muscles. J. Biol. Chem. 251: 725-729, 1976.
118. KIRCHBERGER, M. A., M. TADA, AND A. M. KATZ. Adenosine 3′:5′-monophosphate-dependent protein kinase catalyzed phosphorylation reaction and its relationship to calcium transport in cardiac sarcoplasmic reticulum. J. Biol. Chem. 249: 6166-6173, 1974.
119. KIRCHBERGER, M. A., M. TADA, AND A.M. KATZ. Phospholamban: a regulatory protein of the cardiac sarcoplasmic reticulum. Recent Adv. Stud. Cardiac Struct. Metab. 5: 103-115, 1975.
120. 2+-ATPase protein levels. Circ. Res. 77: 759-764, 1995.
121. 2+ transport and myocardial relaxation. Circ. Res. 75: 245-251, 1994.
122. KORECKY, B., R. ZAK, K. SCHWARTZ, AND V. ASCHENBRENNER. Role of thyroid hormone in regulation of isomyosin composition, contractility, and size of heterotopically isotransplanted rat heart. Circ. Res. 60: 824-830, 1987.
123. KOSS, K. L., AND E. G. KRANIAS. Phospholamban: a prominent regulator of myocardial contractility. Circ. Res. 79: 1059-1063, 1996.
124. 2+-selective channels in lipid bilayers. J. Biol. Chem. 263: 18364-18368, 1988.
125. 2+ transport by cyclic 3′,5′-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta 844: 193-199, 1985.
126. KRANIAS, E. G. Regulation of calcium transport by protein phosphatase activity associated with cardiac sarcoplasmic reticulum. J. Biol. Chem. 260: 11006-11010, 1985.
127. KRANIAS, E. G., AND J. DISALVO. A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum. J. Biol. Chem. 261: 10029-10032, 1986.
128. KRANIAS, E. G., J. L. GARVEY, R. D. SRIVASTAVA, AND R. J. SOLARO. Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline. Biochem. J. 226: 113-121, 1985.
129. KRANIAS, E. G., F. MANDEL, T. WANG, AND A. SCHWARTZ. Mechanism of the stimulation of calcium ion dependent adenosine triphosphatase of cardiac sarcoplasmic reticulum by adenosine 3′,5′-dependent protein kinase. Biochemistry 19: 5434-5439, 1980.
130. 2+-ATPase enzyme. Biochim. Biophys. Acta 749: 62-68, 1983.
131. KRANIAS, E. G., AND R. J. SOLARO. Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature 298: 182-184, 1982.
132. KUO, J. F., AND P. GREENGARD. Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3′,5′-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom. Proc. Natl. Acad. Sci. USA 64: 1349-1355, 1969.
133. LALLI, J., J. M. HARRER, E. G. KRANIAS, AND R. J. PAUL. Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle. Circ. Res. 80: 506-513, 1997.
134. LAMERS, J. M. J., AND J. T. STINIS. Phosphorylation of low molecular weight proteins in purified preparations of rat heart sarcolemma and sarcoplasmic reticulum. Biochim. Biophys. Acta 624: 443-459, 1980.
135. LARAIA, P. J., AND E. MORKIN. Adenosine 3′,5′-monophosphate-dependent membrane phosphorylation: a possible mechanism for the control of microsomal calcium transport in heart muscle. Circ. Res. 35: 298-306, 1974.
136. 2+-ATPase and phospholamban mRNAs are expressed in chronically stimulated rabbit fast-twitch muscle. Eur. J. Biochem. 185: 51-54, 1989.
137. LEPEUCH, C. J., J.-C. GUILLEUX, AND J. G. DEMAILLE. Phospholamban phosphorylation in the perfused rat heart is not solely dependent on β-adrenergic stimulation. FEBS Lett. 114: 165-168, 1980.
138. LEPEUCH, C. J., J. HAIECH, AND J. G. DEMAILLE. Concerted regulation of cardiac sarcoplasmic reticulum calcium transport by cyclic adenosine monophosphate-dependent and calcium-calmodulin-dependent phosphorylations. Biochemistry 18: 5150-5157, 1979.
139. LEPEUCH, C. J., D. A. M. LEPEUCH, AND J. G. DEMAILLE. Phospholamban, activator of the cardiac sarcoplasmic reticulum calcium pump: physicochemical properties and diagonal purification. Biochemistry 19: 3368-3373, 1980.
140. 2+-calmodulin-dependent protein phospholamban kinase. Methods Enzymol. 102: 261-278, 1983.
141. LI, C., J. H. WANG, AND J. COLYER. Immunological detection of phospholamban phosphorylation states facilitates the description of the mechanism of phosphorylation and dephosphorylation. Biochemistry 29: 4535-4540, 1990.
142. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc. Res. 31: 625-632, 1996.
143. LINDEMANN, J. P. α-Adrenergic stimulation of sarcolemmal protein phosphorylation and slow responses in intact myocardium. J. Biol. Chem. 261: 4860-4867, 1986.
144. 2+-ATPase activity in guinea pig ventricles. J. Biol. Chem. 258: 464-471, 1983.
145. 2+-calmodulin-dependent mechanisms. J. Biol. Chem. 260: 4516-4525, 1985.
146. 2+ transport in guinea pig ventricles. J. Biol. Chem. 260: 13122-13129, 1985.
147. 2+ handling by phosphorylation status in mouse fast- and slow-twitch skeletal muscle fibers. Am. J. Physiol. 273 (Cell Physiol. 42): C1915-C1924, 1997.
148. LOMPRE, A.-M., M. ANGER, AND D. LEVITSKY. Sarco(endo)plasmic reticulum calcium pumps in the cardiovascular system: function and gene expression. J. Mol. Cell. Cardiol. 26: 1109-1121, 1994.
149. LOUIS, C. F., M. HOGAN, AND J. TURNQUIST. Properties of the 23,000-Da phosphoprotein in cardiac sarcolemma and sarcoplasmic reticulum. Arch. Biochem. Biophys. 246: 98-107, 1986.
150. LOUIS, C. F., AND B. JARVIS. Affinity labeling of calmodulin-binding components in canine cardiac sarcoplasmic reticulum. J. Biol. Chem. 257: 15187-15191, 1982.
151. LOUIS, C. F., M. MOFFITT, AND B. JARVIS. Factors that modify the molecular size of phospholamban, the 23,000-dalton cardiac sarcoplasmic reticulum phosphoprotein. J. Biol. Chem. 257:15182-15186, 1982.
152. LOUIS, C. F., J. TURNQUIST, AND B. JARVIS. Phospholamban stoichiometry in canine cardiac muscle sarcoplasmic reticulum. Neurochem. Res. 12: 937-941, 1987.
153. LU, Y.-Z., Z.-C. XU, AND M. A. KIRCHBERGER. Evidence for an effect of phospholamban on the regulatory role of ATP in calcium uptake by the calcium pump of the cardiac sarcoplasmic reticulum. Biochemistry 32: 3105-3111, 1993.
154. LUDLAM, C, F. C., I. T. ARKIN, X.-M. LIU, M. S. ROTHMAN, P. RATH, S. AIMOTO, S. O. SMITH, D. M. ENGELMAN, AND K. J. ROTHSCHILD. Fourier transform infrared spectroscopy and site-directed isotope labeling as a probe of local secondary structure in the transmembrane domain of phospholamban. Biophys. J. 70: 1728-1736, 1996.
155. LUO, W., I. L. GRUPP, J. HARRER, S. PONNIAH, G. GRUPP, J. J. DUFFY, T. DOETSCHMAN, AND E. G. KRANIAS. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ. Res. 75: 401-409, 1994.
156. LUPAS, A. Coiled coils: new structures and new functions. Trends Biochem. Sci. 21: 375-382, 1996.
157. LYTTON, J., M. WESTLIN, B. E. SCOTT, G. E. SHULL, AND D. H. MACLENNAN. Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J. Biol. Chem. 267: 14483-14489, 1992.
158. MACDOUGALL, L. K., L. R. JONES, AND P. COHEN. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur. J. Biochem. 196: 725-734, 1991.
159. MAHONY, L., AND L. R. JONES. Developmental changes in cardiac sarcoplasmic reticulum in sheep. J. Biol. Chem. 261: 15257-15265, 1986.
160. MALASHKEVICH, V. N., R. A. KAMMERER, V. P. EFIMOV, T. SCHULTHESS, AND J. ENGEL. The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel? Science 274: 761-765, 1996.
161. MANALAN, A. S., AND L. R. JONES. Characterization of the intrinsic cAMP-dependent protein kinase activity and endogenous substrates in highly purified cardiac sarcolemmal vesicles. J. Biol. Chem. 257: 10052-10062, 1982.
162. MASLENNIKOV, I. V., A. G. SOBOL, J. ANAGLI, P. JAMES, T. VORHERR, A. V.
163. MAYER, E. J., E. McKENNA, V. M. GARSKY, C. J. BURKE, H. MACH, C. R. MIDDAUGH, M. SARDANA, J. S. SMITH, AND R. G. JOHNSON. Biochemical and biophysical comparison of native and chemically synthesized phospholamban and a monomeric phospholamban analog. J. Biol. Chem. 271: 1669-1677, 1996.
164. MEYER, M., W. SCHILLINGER, B. PIESKE, C. HOLUVARSCH, C. HEILMANN, H. POSIVAL, G. KUWAJIMA, K. MIKOSHIBA, H. JUST, AND G. HASENFUSS. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784, 1995.
165. 2+-ATPase by quercetin. J. Biol. Chem. 271: 24517-24525, 1996.
166. MIYAKODA, G., A. YOSHIDA, H. TAKISAWA, AND T. NAKAMURA. β-Adrenergic regulation of contractility and protein phosphorylation in spontaneously beating isolated rat myocardial cells. J. Biochem. 102: 211-224, 1987.
167. MOLLA, A., J. P. CAPONY, AND J. G. DEMAILLE. Cardiac sarcoplasmic-reticulum calmodulin-binding proteins, modulation of calmodulin binding to phospholamban by phosphorylation. Biochem. J. 226: 859-865, 1985.
168. 2+-ATPase and phospholamban mRNAs during rat heart development. Circ. Res. 76: 616-625, 1995.
169. MORGAN, J. P. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N. Engl. J. Med. 325: 625-632, 1991.
170. 2+)-ATPase: mechanism of regulation and site of monoclonal antibody interaction. J. Biol. Chem. 266: 11270-11275, 1991.
171. MORTISHIRE-SMITH, R. J., S. M. PITZENBERGER, C. J. BURKE, C. R. MIDDAUGH, V. M. GARSKY, AND R. G. JOHNSON. Solution structure of the cytoplasmic domain of phospholamban: phosphorylation leads to a local perturbation in secondary structure. Biochemistry 34: 7603-7613, 1995.
172. 2+ uptake in sarcoplasmic reticulum from normal and failing hearts. J. Clin. Invest. 85: 1698-1702, 1990.
173. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90: 653-657, 1994.
174. MOVSESIAN, M. A., M. NISHIKAWA, AND R. S. ADELSTEIN. Phosphorylation of phospholamban by calcium-activated, phospholipid-dependent protein kinase. J. Biol. Chem. 259: 8029-8032, 1984.
175. MUNDINA-WEILENMANN, C., L. VITTONE, M. ORTALE, G. C. DE CINGOLANI, AND A. MATTIAZZI. Immunodetection of phosphorylation sites give new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J. Biol. Chem. 271: 33561-33567, 1996.
176. 2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc. Natl. Acad. Sci. USA 86: 2966-2970, 1989.
177. 2+-calmodulin-dependent protein kinase system. J. Mol. Cell. Cardiol. 24: 387-396, 1992.
178. NEGASH, S., L. T. CHEN, D. J. BIGELOW, AND T. C. SQUIER. Phosphorylation of phospholamban by cAMP-dependent protein kinase enhances interactions between Ca-ATPase polypeptide chains in cardiac sarcoplasmic reticulum membranes. Biochemistry 35: 11247-11259, 1996.
179. 2+ transport and contractility. J. Mol. Cell. Cardiol. In press.
180. NEUMANN, J., T. ESCHENHAGEN, L. R. JONES, B. LINCK, W. SCHMITZ, H. SCHHOZ, AND N. ZIMMERMAN. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J. Mol. Cell. Cardiol. 29: 265-272, 1997.
181. NEUMANN, J., R. C. GUPTA, W. SCHMITZ, H. SCHOLZ, A. C. NAIRN, AND A. M. WATANABE. Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ. Res. 69: 1450-1457, 1991.
182. NIMMO, H. G., AND P. COHEN. Hormonal control of protein phosphorylation. Adv. Cyclic Nucleotide Res. 8: 145-266, 1977.
183. 2+/calmodulin-dependent phosphorylation or by interaction with phospholamban. J. Biol. Chem. 271: 14206-14213, 1996.
184. OTSU, K., M. PERIASAMY, M. DIFILIPPANTONIO, M. UPPENDER, D. C. WARD, AND D. H. MACLENNAN. Chromosome mapping of five human cardiac and skeletal muscle sarcoplasmic reticulum genes. Genomics 17: 507-509, 1993.
185. PALMER, C. J., B. T. SCOTT, AND L. R. JONES. Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J. Biol. Chem. 266: 11123-11130, 1991.
186. PLANK, B., C. PIFL, G. HELLMANN, W. WYSKOVSKY, R. HOFFMANN, AND J. SUKO. Correlation between calmodulin-dependent increase in the rate of calcium transport and calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. Eur. J. Biochem. 136: 215-221, 1983.
187. PRESTI, C. F., L. R. JONES, AND J. P. LINDEMANN. Isoproterenolinduced phosphorylation of a 15-kDa sarcolemmal substrate in intact myocardium. J. Biol. Chem. 260: 3860-3867, 1985.
188. PRESTI, C., B. T. SCOTT, AND L. R. JONES. Identification of an endogenous protein kinase C activity and its intrinsic 15-kilodalton substrate in purified canine cardiac sarcolemmal vesicles. J. Biol. Chem. 260: 13879-13889, 1985.
189. QUIRK, P. G., V. B. PATCHELL, J. COLYER, G. A. DRAGO, AND Y. GAO. Conformational effects of serine phosphorylation in phospholamban peptides. Eur. J. Biochem. 236: 85-91, 1996.
190. 2+ pump of bovine pulmonary artery. Cell Calcium 11: 261-268, 1990.
191. RAEYMAEKERS, L., F. HOFMANN, AND R. CASTEELS. Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem. J. 252: 269-273, 1988.
192. RAEYMAEKERS, L., AND L. R. JONES. Evidence for the presence of phospholamban in the endoplasmic reticulum of smooth muscle. Biochim. Biophys. Acta 882: 258-265, 1986.
193. 2+-ATPase. J. Biol. Chem. 270: 9390-9397, 1995.
194. 2+/calmodulin-dependent protein kinase. J. Biol. Chem. 271: 14964-14970, 1996.
195. r sarcolemmal protein. FEBS Lett. 129: 277-281, 1981.
196. ROCKMAN, H. A., S. ONO. R. S. ROSS, L. R. JONES, M. KARIMI, V. BHARGAVA, J. ROSS, JR., AND K. R. CHIEN. Molecular and physiological alterations in murine ventricular dysfunction. Proc. Natl. Acad. Sci. USA 91: 2694-2698, 1994.
197. SABINE, B., R. WILLENBROCK, H. HAASE, P. KARCZEWSKI, G. WALLUKAT, R. DIETZ, AND E.-G. KRAUSE. Cyclic GMP-mediated phospholamban phosphorylation in intact cardiomyocytes. Biochem. Biophys. Res. Commun. 214: 75-80, 1995.
198. SARCEVIC, B., V. BROOKES, T. J. MARTIN, B. E. KEMP, AND P. J. ROBINSON. Atrial natriuretic peptide-dependent phosphorylation of smooth muscle cell particulate fraction proteins is mediated by cGMP-dependent protein kinase. J. Biol. Chem. 264: 20648-20654, 1989.
199. 2+ pump ATPase. J. Biol. Chem. 267: 1674-1679, 1992.
200. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228, 1995.
201. 2+-activated protease. J. Biol. Chem. 259: 8550-8557, 1984.
202. 2+ uptake in mammalian ventricular myocytes. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1344-H1349, 1991.
203. SHAMOO, A. E., I. S. AMBUDKAR, M. S. JACOBSON, AND J. BIDLACK. Regulation of calcium transport in cardiac sarcoplasmic reticulum. Curr. Top. Membr. Transp. 25: 131-145, 1985.
204. 8 on calcium transport and molecular dynamics in cardiac sarcoplasmic reticulum. Biochemistry 35: 13393-13399, 1996.
205. SIMMERMAN, H. K. B., J. H. COLLINS, J. L. THEIBERT, A. D. WEGENER, AND L. R. JONES. Sequence analysis of phospholamban: identification of phosphorylation sites and two major structural domains. J. Biol. Chem. 261: 13333-13341, 1986.
206. SIMMERMAN, H. K. B., Y. M. KOBAYASHI, J. M. AUTRY, AND L. R. JONES. A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J. Biol. Chem. 271: 5941-5946, 1996.
207. SIMMERMAN, H. K. B., Y. M. KOBAYASHI, B. STRIFLER, AND L. R. JONES. Subunit interactions stabilizing the phospholamban pentamer (Abstract). Biophys. J. 66: A178, 1994.
208. SIMMERMAN, H. K. B., D. E. LOVELACE, AND L. R. JONES. Secondary structure of detergent-solubilized phospholamban, a phosphorylatable, oligomeric protein of cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta 997: 322-329, 1989.
209. 2+ transport and muscle relaxation. J. Biol. Chem. 272: 18862-18868, 1997.
210. SLACK, J. P., I. L. GRUPP, W. LUO, AND E. G. KRANIAS. Phospholamban ablation enhances relaxation in the murine soleus. Am. J. Physiol. 273 (Cell Physiol. 42): C1-C6, 1997.
211. 2+-ATPase inhibition by phospholamban. Biochem. Biophys. Res. Commun. 226: 352-355, 1996.
212. 2+-ATPase and phospholamban. Curr. Opin. Struct. Biol. 7: 550-556, 1997.
213. STRASBURG, G. M., T. P. HANSON, H. X. OUYANG, AND C. F. LOUIS. Localization and functional role of the calmodulin-binding domain of phospholamban in cardiac sarcoplasmic reticulum vesicles. Biochim. Biophys. Acta 1149: 249-259, 1993.
214. SUKO, J. The calcium pump of cardiac sarcoplasmic reticulum. Functional alterations at different levels of thyroid state in rabbits. J. Physiol. (Lond.) 228: 563-582, 1973.
215. SULAKHE, P. V., AND X. T. VO. Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases, and depolarization. Mol. Cell. Biochem. 149-150: 103-126, 1995.
216. SUZUKI, T., P. LIU, AND J. H. WANG. Rapid purification of phospholamban by monoclonal antibody immunoaffinity chromatography. Biochem. Cell Biol. 65: 302-309, 1987.
217. 2+ pump and blocking of phospholamban phosphorylation and dephosphorylation by a phospholamban monoclonal antibody. J. Biol. Chem. 261: 7018-7023, 1986.
218. SUZUKI, T., AND J. H. WANG. The phosphorylation of purified phospholamban by cyclic AMP-dependent protein kinase is stimulated by phosphatidylinositol. J. Biol. Chem. 262: 3880-3885, 1987.
219. SZYMANSKA, G., I. GRUPP, J. P. SLACK, J. M. HARRER, AND E. G. KRANIAS. Alterations in sarcoplasmic reticulum calcium uptake, relaxation parameters and their responses to β-adrenergic agonists in the developing rabbit heart. J. Mol. Cell. Cardiol. 27: 1819-1829, 1995.
220. 2+ pump by phospholamban in reconstituted phospholipid vesicles. Membr. Biochem. 9: 191-202, 1991.
221. 2+-ATPase by phospholamban and negatively charged phospholipids in reconstituted phospholipid vesicles. Mol. Cell. Biochem. 114: 65-71, 1992.
222. TADA, M. Molecular structure and function of phospholamban in regulating the calcium pump from sarcoplasmic reticulum. Ann. NY Acad. Sci. 671: 92-102, 1992.
223. TADA, M., AND M. INUI. Regulation of calcium transport by the ATPase-phospholamban system. J. Mol. Cell. Cardiol. 15: 565-575, 1983.
224. TADA, M., M. INUI, M. YAMADA, M. KADOMA, T. KUZUYA, H. ABE, AND S. KAKICHI. Effects of phospholamban phosphorylation catalyzed by adenosine 3′,5′-monophosphate and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum. J. Mol. Cell. Cardiol. 15: 335-346, 1983.
225. 2+ pump ATPase by cAMP-dependent phosphorylation of phospholamban. Bioessays 10: 157-163, 1989.
226. 2+ pump from cardiac sarcoplasmic reticulum. Methods Enzymol. 157: 107-154, 1988.
227. TADA, M., AND A. M. KATZ. Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu. Rev. Physiol. 44: 401-423, 1982.
228. TADA, M., M. A. KIRCHBERGER, AND A. M. KATZ. Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3′,5′-monophosphate-dependent protein kinase. J. Biol. Chem. 250: 2640-2647, 1975.
229. TADA, M., M. A. KIRCHBERGER, AND H.-C. LI. Phosphoprotein phosphatase-catalyzed dephosphorylation of the 22,000 dalton phosphoprotein of cardiac sarcoplasmic reticulum. J. Cyclic Nucleotide Res. 1: 329-338, 1975.
230. TADA, M., M. A. KIRCHBERGER, D. I. REPKE, AND A. M. KATZ. The stimulation of calcium transport in cardiac sarcoplasmic reticulum by adenosine 3′,5′-monophosphate-dependent protein kinase. J. Biol. Chem. 249: 6174-6180, 1974.
231. TADA, M., F. OHMORI, N. KINOSHITA, AND H. ABE. Cyclic AMP regulation of active calcium transport across membranes of sarcoplasmic reticulum: role of the 22,000-dalton protein phospholamban. Adv. Cyclic Nucleotide Res. 9: 355-369, 1978.
232. TADA, M., M. YAMADA, M. KADOMA, M. INUI, AND F. OHMORI. Calcium transport by cardiac sarcoplasmic reticulum and phosphorylation of phospholamban. Mol. Cell. Biochem. 46: 73-95, 1982.
233. 2+-dependent ATPase and calcium transport by cardiac sarcoplasmic reticulum: effect of cyclic AMP-dependent protein kinase-catalyzed phosphorylation of phospholamban. J. Biol. Chem. 255: 1985-1992, 1980.
234. TALOSI, L., I. EDES, AND E. KRANIAS. Intracellular mechanisms mediating reversal of β-adrenergic stimulation in intact beating hearts. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H791-H797, 1993.
235. TATULIAN, S. A., L. R. JONES, L. G. REDDY, D. L. STOKES, AND L. K. TAMM. Secondary structure and orientation of phospholamban reconstituted in supported bilayers from polarized attenuated total reflection FTIR spectroscopy. Biochemistry 34: 4448-4456, 1995.
236. TERZI, E., L. POTEUR, AND E. TRIFILIEFF. Evidence for a phosphorylation-induced confomational change in phospholamban cytoplasmic domain by CD analysis. FEBS Lett. 309: 413-416, 1992.
237. TOYOFUKU, T., D. D. DOYLE, R. ZAK, AND L. KORDYLEWSKI. Expression of phospholamban mRNA during early avian muscle morphogenesis is distinct from that of α-actin. Dev. Dynamics 196: 103-113, 1993.
238. 2+-ATPases. J. Biol. Chem. 267: 14490-14496, 1992.
239. 2+/calmodulin-dependent protein kinase. J. Biol. Chem. 269: 26492-26496, 1994.
240. 2+-ATPase of sarcoplasmic reticulum that affect functional association with phospholamban. J. Biol. Chem. 268: 2809-2815, 1993.
241. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 269: 3088-3094, 1994.
242. 2+-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban. J. Biol. Chem. 269: 22929-22932, 1994.
243. TOYOFUKU, T., AND R. ZAK. Characterization of cDNA and genomic sequences encoding a chicken phospholamban. J. Biol. Chem. 266: 5375-5383, 1991.
244. TSIEN, R. W. Cyclic AMP and contractile activity in heart. Adv. Cyclic Nucleotide Res. 8: 363-420, 1977.
245. UYEDA, A., K. KITANO, J. FUJII, M. KADOMA, M. TADA, AND S. TANAKA. The cDNA sequence of the major phospholamban mRNA in canine cardiac ventricular muscle. Nucleic Acids Res. 15: 6738, 1987.
246. 2+ pumps and their modulation by phospholamban. Biochem. J. 286: 591-595, 1992.
247. VERBOOMEN, H., F. WUYTACK, J. A. EGGERMONT, S. DE JAEGERE, L. MISSIAEN, L. RAEYMAEKERS, AND R. CASTEELS. cDNA cloning and sequencing of phospholamban from pig stomach smooth muscle. Biochem. J. 262: 353-356, 1989.
248. VITTONE, L., C. MUNDINA, G. C. DE CINGOLANI, AND A. MATTIAZZI. cAMP and calcium-dependent mechanisms of phospholamban phosphorylation in intact hearts. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H318-H325, 1990.
249. 2+-calmodulin dependent phospholamban phosphorylation on the relaxant effect of β-adrenergic agonists. Mol. Cell. Biochem. 124: 33-42, 1993.
250. VORHERR, T., M. CHIESI, R. SCHWALLER, AND E. CARAFOLI. Regulation of the calcium ion pump of sarcoplasmic reticulum: reversible inhibition by phospholamban and by the calmodulin binding domain of the plasma membrane calcium ion pump. Biochemistry 31: 371-376, 1992.
251. VORHERR, T., A. WRZOSEK, M. CHIESI, AND E. CARAFOLI. Total synthesis and functional properties of the membrane-intrinsic protein phospholamban. Protein Sci. 2: 339-347, 1993.
252. VOSS, J., L. R. JONES, AND D. D. THOMAS. The physical mechanism of calcium pump regulation in the heart. Biophys. J. 67: 190-196, 1994.
253. VOSS, J., J. E. MAHANEY, L. R. JONES, AND D. D. THOMAS. Molecular dynamics in mouse atrial tumor sarcoplasmic reticulum. Biophys. J. 68: 1787-1795, 1995.
254. WATANABE, Y., Y. KIJIMA, M. KADOMA, M. TADA, AND T. TAKAGI. Molecular weight determination of phospholamban oligomer in the presence of sodium dodecyl sulfate: application of low-angle laser light scattering photometry. J. Biochem. 110: 40-45, 1991.
255. WATRAS, J. Regulation of calcium uptake in bovine aortic sarcoplasmic reticulum by cyclic AMP-dependent protein kinase. J. Mol. Cell. Cardiol. 20: 711-723, 1988.
256. WEGENER, A. D., AND L. R. JONES. Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels: evidence for a protein structure consisting of multiple identical phosphorylatable subunits. J. Biol. Chem. 259: 1834-1841, 1984.
257. WEGENER, A. D., H. K. B. SIMMERMAN, J. LIEPNIEKS, AND L. R. JONES. Proteolytic cleavage of phospholamban purified from canine cardiac sarcoplasmic reticulum vesicles: generation of a low resolution model of phospholamban structure. J. Biol. Chem. 261: 5154-5159, 1986.
258. WEGENER, A. D., H. K. B. SIMMERMAN, J. P. LINDEMANN, AND L. R. JONES. Phospholamban phosphorylation in intact ventricles: phosphorylation of serine 16 and threonine 17 in response to β-adrenergic stimulation. J. Biol. Chem. 264: 11468-11474, 1989.
259. WEILENMANN, C. M. DE, L. VITTONE, AND A. MATTIAZZI. Dissociation between contraction and relaxation: the possible role of phospholamban phosphorylation. Basic Res. Cardiol. 82: 507-516, 1987.
260. WILL, H., I. KÜTTNER, C. KEMSIES, R. VETTER, AND E. SCHUBERT. Comparative analysis of phospholamban phosphorylation in crude membranes of vertebrate hearts. Experientia 41: 1052-1054, 1985.
261. WILL, H., T. S. LEVCHENKO, D. O. LEVITSKY, V. N. SMIRNO, AND A. WOLLENBERGER. Partial characterization of protein kinase-catalyzed phosphorylation of low molecular weight proteins in purified preparations of pigeon heart sarcolemma and sarcoplasmic reticulum. Biochim. Biophys. Acta 543: 175-193, 1978.
262. 2+. Am. J. Physiol. 271 (Cell Physiol. 40): C391-C397, 1996.
263. 2+-dependent ATPase in cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta 461: 441-459, 1977.
264. WRAY, H. L., R. R. GRAY, AND R. A OLSSON. Cyclic adenosine 3′,5′-monophosphate-stimulated protein kinase and a substrate associated with cardiac sarcoplasmic reticulum. J. Biol. Chem. 248: 1496-1498, 1973.
265. 2+ dynamics, contractility, or phospholamban phosphorylation. J. Biol. Chem. 269: 19151-19156, 1994.
266. 2+/calmodulin-dependent protein kinase. J. Biol. Chem. 268: 8394-8397, 1993.
267. XU, Z.-C., AND M. A. KIRCHBERGER. Modulation by polyelectrolytes of canine cardiac microsomal calcium uptake and the possible relationship to phospholamban. J. Biol. Chem. 264: 16644-16651, 1989.
268. YOUNG, E. F., M. J. MCKEE, D. G. FERGUSON, AND E. G. KRANIAS. Structural characterization of phospholamban in cardiac sarcoplasmic reticulum membranes by cross-linking. Membr. Biochem. 8: 95-106, 1989.
269. YOSHIDA, A., H. TAKISAWA, AND T. NAKAMURA. Bi-directional regulation of dephosphorylation of cAMP-dependent phosphorylated proteins by cAMP and calcium in permeabilized rat heart cells. J. Biochem. 106: 894-899, 1989.